In Vivo Radiotracer Imaging

Textbook of in vivo Imaging in Vertebrates

Volumn , Issue , 2007, Pages 103-147

  Tavitian, Bertrand ^a,b   Trébossen, Régine ^b,c   Pasqualini, Roberto ^d   Dollé, Frédéric ^b,c  

^a INSERM   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^c Laboratoire d'ImagerieMoléculaire Expérimentale   (France)

^d CIS Bio International   (France)

Author keywords

Gamma emitting radiotracer radiochemistry; in vivo radiotracer imaging; Radiotracer imaging with gamma emitters; Radiotracer principle and radiotracer imaging; Receptor mapping and cardiac imaging

Indexed keywords

EID: 84889828501     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470029596.ch4     Document Type: Chapter

References (46)

1. Adloff, J. P., Guillaumont, R., 1993. Fundamentals of Radiochemistry, CRC Press Inc., Boca Raton, FL.
2. Bailey, D. L., Townsend, D. W., Valk, P. E., Maisley, M. N., (Eds.), 2005. Positron Emission Tomography, Springer, London.
3. Banerjee, S. R., Maresca K. P., Francesconi L., Valli-ant J., et al., 2005. "New directions in the coordination chemistry of 99mTc: A reflection on technetium core structures and a strategy for new chelate design." Nucl. Med. Biol. 32, 1-20.
4. Bombardieri, E., Aktolun, C., Baum, R. P., Bishof-Delaloye, A., Buscombe, J., Chatal, J. F., Maffioli L., et al., 2003. "131I/123I-Metaiodobenzylguani-dine (MIBG) scintigraphy: Procedure Guidelines for Tumor Imaging. Eur. J. Nucl. Med. Mol. Imaging 30, B132-B139. Brooks, D., 2005. "PET and SPECT in CNS drug development." NeuroRx 2, 226.
5. Browne, E., Dairiki, J. M., Doebler, R. E., 1978. In: Lederer, C. M., Shirley, V.S. (Eds), Table of Isotopes, Wiley-Interscience Pub., New York, Chiche-ster, Brisbane, Toronto, pp. 1-1523.
6. Bushberg, J., Seibert, J., Leidholdt, E., Boone, J., 2001. The Essential Physics of Medical Imaging, Lippincott, Williams and Wilkins, Philadelphia.
7. Clark, J. C., Buckingham, P. D., 1975. In: Clark, J.,C., Buckingham, P.D. (Ed.), Short-Lived Radioactive Gases for Clinical Use, Butterworths, London, Boston, pp. 1-353.
8. Clark, M. J., Podbielski, L., 1987. "Medical diagnostic imaging with complexes of 99mTc."Coord. Chem. Rev. 78, 253-331.
9. Crouzel, C., Langstrom, B., Pike, V., Coenen, H. H., 1987. "Recommendations for a practical production of [11C]methyl iodide." Appl. Rad. Isot. 38, 601-603.
10. de Bruin, B., Kühnast, B., Hinnen, F., Yaouancq, L., Amessou, M., Johannes, L., Samson, A., Boisgard, R., Tavitian, B., Dolle, F., 2005. "1-[3-(2-[18F]Fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: Design, synthesis and radiosynthesis ofa new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. Bioconj. Chem. 16, 406-420.
11. Deutsch, E., Libson, K., Jurisson, S., 1983. "Techne-tium chemistry and technetium radiopharmaceuti-cals. Prog. Inorg. Chem. 30, 73-139.
12. Dilworth, J. R., Parrots, S. J., 1998. "The biomedical chemistry of technetium and rhenium. Chem. Soc. Rev. 27, 43-55.
13. Dolci, L., Dolle, F., Jubeau, S., Vaufrey, F., Crouzel, C, 1999. "2-[18F]Fluoropyridines by no-carrier-added nucleophilic aromatic substitution with K[18F]F-K222 - a comparative study." J. Label Coepds. Radiopharm. 42, 975-985.
14. Doll, F., Valette, H., Bottlaender, M., Hinnen, F., Vaufrey, F., Guenther, I., Crouzel, C., 1998. "Synthesis of 2-[18F]fluoro-3-[2(S)-2-azetidinyl-methoxy]pyridine, a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors." J. Label Compds. Radiopharm. 41, 451-463.
15. Douglas, B., McDaniel, D. H., Alexander, J. J., 1983. Concept and Models of Inorganic Chemistry, second ed. John Wiley & Sons, Inc., New-York (NY).
16. Fichna, J., and Janecka, A., 2003. "Synthesis of target specific radiolabeled peptides for diagnostic imaging." Bioconjug. Chem. 14, 3-17.
17. Fritzberg, A. R., Abrams, P.G, Beaumier, P. L., Kasina, P. L., Morgan, A. C., et al., 1988. "Specific and stable labelling of antibodies with technetium -99m with a diamide dithiolate chelating agent. Proc. Natl. Acad. Sci. USA 85, 4025-4029.
18. http://www.webelements.com/webelements/ele-ments/text/periodic-table/rad io.html
19. http://www.nrc.gov/reading-rm/doc-collections/cfr/part020/appb/
20. Garron, J.-Y., Moinereau, M., Pasqualini, R., Sacca-vini, J.-C., 1991. "Direct 99mTc labelling of monoclonal antibodies: Radiolabeling and in vitro stability." Int. J. Rad. Appl. Instrum. B18, 695-703.
21. Huheey, J. E., Keiter, E. A., Keither, R.L., 1993. Inorganic Chemistry: Principles of Structure and Reactivity, fourth ed. Harper Collins College Publisher, New York (NY).
22. Ichise, M., Meyer, J. H., Yonekura, Y., 2001. "An introduction to PET and SPECT neuroreceptor quantification models." J. Nucl. Med. 42 (5), 755-763.
23. Jeavons, A., Parkman, C., Donath, A., Frey, P., Herlin, G., Hood, K., Magnanini, R., Townsend, D., 1983. "The high-density avalanche chamber for positron emission tomography." IEEE Trans. Nucl. Sci. NS-30, 640-645.
24. Joliot, F., Curie, I., 1934. "Artificial production of a new kind of radioelement." Nature 133, 201-202.
25. Kilbourn, M. R., 1990. In: Kilbourn, M.R. (ed). Fluorine-18 Labelling of Radiopharmaceuticals (Nuclear Science Series), National Academy Press, Washington, pp. 1-149.
26. Kühnast, B., Lagnel de Bruin, B., Hinnen, F., Tavi-tian, B., Dolle, F., 2004. "Design and synthesis of a new [18F]fluoropyridine-based haloacetamide reagent for the labeling of oligonucleotides: 2-Bromo-N-[3-(2-[18F]fluoro-pyridin-3-yloxy)-pro-pyl]-acetamide. Bioconj. Chem. 15, 617-627.
27. Lammertsma, A. A., Hume, S. P., 1996. Simplified reference tissue model for PET receptor studies. Neuroimage 4(3 Pt. 1), 153-158.
28. Langstrom, B., Kihlberg, T., Bergstrom, M., Antoni, G., Bjorkman, M., Forngren, B. H., Forngren, T., Hartvig, P., Markides, K., Yngve, U., Ogren, M. 1999. "Compounds labelled with short-lived beta-plus-emitting radionuclides and some applications in life sciences. The importance of time as a parameter. Acta. Chem. Scand. 53, 651-669.
29. Logan, J., Fowler, J. S., Volkow, N. D., Wang, G. J., Ding, Y. S., Alexoff, D. L., 1996. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 16(5), 834-840.
30. Liu, S., Edwards, D. S., 2003. "Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals. Bioconjugate Chem 14, 7-34.
31. March, J. A., Smith, M. B., 2001. Advanced Organic Chemistry. Reactions, Mechanisms and Structure, fifth ed. John Wiley & Sons, New York.
32. Mather, S. J., Ellison, D., 1990. "Reduction-mediated technetium-99m labelling of monoclonal antibodies. J. Nucl. Med. 31, 692-697.
33. Nicolini, M., Bandoli, G., Mazzi, U., (Eds.), 1983, 1986, 1990, 1995, 1999, 2002. Technetium and Rhenium in Chemistry and Nuclear Medicine, Vol. I to VI. Verona: Ed. Cortina International, Raven Press, New York.
34. Paik, C. H., Phan, L. N., Hong, J. J., Sahami, M. S., Reba, R. C., Steigman, J., Eckelman, W. C., 1985. "The labelling of high affinity sites of antibodies with 99mTc. Int. J. Nucl. Med. Biol. 2, 3-8.
35. Patlak, C. S., Blasberg, R. G., Fenstermacher, J. D., 1983. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3(1), 1-7.
36. Schwochau, K., 1994. "Technetium radiopharmaceu-ticals: fundamentals, synthesis, structure and development. Angew. Chem. Int. Ed. Engl. 33, 2258-2267.
37. Steigman, J., Williams, H. P., Soloman, N. A., 1975. "The importance of the protein sulfhydryl groups in HSA labeling with technetium-99m. J. Nucl. Med. 16, 573 (abs.).
38. Tatsch, K., Asenbaum, S., Bartenstein, P., Catafau, A., Halldin, C., Pilowsky, L. S., Pupi, A., 2002. "EANM procedure guidelines for brain neurotransmission SPET using 123I-labelled dopamine transporter ligands. Eur. J. Nucl. Med. Mol. Imaging 29, B23-B29.
39. Verbruggen, A., 1996. Bifunctional chelators for tech-netium-99m. In: Mather, S.J. (Ed.), Current Directions in Radiopharmaceutical Research and Development, Kluwer Academic Publisher, Dordrecht (NL), pp. 31-46.
40. Verbruggen, A.M., 1990. "Radiopharmaceuticals: State of the art." Eur. J. Nucl. Med. 17, 346-364.
41. Wagner, H. N., Szabo, Z., Buchanan, J. W., (Eds.), 1995. Principles of Nuclear Medicine, Saunders, Philadelphia.
42. Webb, A., 2003. Introduction to Biomedical Imaging, John Wiley & Sons, Inc., Hoboken, New Jersey.
43. Weiner, R. E., Thakur, M. L., 2001. "Radiolabeled peptides in diagnosis and therapy. Semin. Nucl. Med. 31, 296-311.
44. Welch, M. J., 1977. In: Welch, M. J. (Ed). Radiopharmaceuticals and other Compounds Labeled with Short-Lived Radionuclides, Pergamon Press, Oxford, New York, Toronto, Sydney, Paris, Frankfurt, pp. 1-246.
45. Welch, M. J., Redvanly, C. S., 2003. In: Welch, M. J., Redvanly, C.S. (Eds.). Handbook of Radiopharmaceuticals - Radiochemistry and Applications, Wiley-Interscience Pub., New York, Chichester, Brisbane, Toronto, pp. 1-848.
46. Wirrwar, A., Schramm, N., Vosberg, H., Muller-Gartner, H. W., 2001. "High resolution SPECT in small animal research." Rev. Neurosci. 12(2), 187-93.